Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study.

Journal: JAMA dermatology
Published Date:

Abstract

IMPORTANCE: The use of artificial intelligence (AI) is expanding throughout the field of medicine. In dermatology, researchers are evaluating the potential for direct-to-patient and clinician decision-support AI tools to classify skin lesions. Although AI is poised to change how patients engage in health care, patient perspectives remain poorly understood.

Authors

  • Caroline A Nelson
    Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Lourdes Maria PĂ©rez-Chada
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Andrew Creadore
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sara Jiayang Li
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kelly Lo
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Priya Manjaly
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ashley Bahareh Pournamdari
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Elizabeth Tkachenko
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • John S Barbieri
    Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Justin M Ko
    Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Alka V Menon
    Department of Sociology, Yale University, New Haven, Connecticut.
  • Rebecca Ivy Hartman
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Arash Mostaghimi
    Harvard Medical School, Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.